In Brief
Essuman et al. demonstrate that the TIR domains from many prokaryotic proteins possess intrinsic NAD + cleavage activity.
Their findings suggest that the primordial function of the TIR domain is to cleave NAD + , and that this large class of proteins is a central and previously unappreciated regulator of metabolism.
SUMMARY
The Toll/interleukin-1 receptor (TIR) domain is the signature signaling domain of Toll-like receptors (TLRs) and their adaptors, serving as a scaffold for the assembly of protein complexes for innate immune signaling [1, 2] . TIR domain proteins are also expressed in plants, where they mediate disease resistance [3, 4] , and in bacteria, where they have been associated with virulence [5] [6] [7] [8] [9] . In pursuing our work on axon degeneration [10] , we made the surprising discovery that the TIR domain of SARM1 (sterile alpha and TIR motif containing 1), a TLR adaptor protein, has enzymatic activity [11] . Upon axon injury, the SARM1 TIR domain cleaves nicotinamide adenine dinucleotide (NAD + ), destroying this essential metabolic co-factor to trigger axon destruction [11, 12] . Whereas current studies of TIR domains focus on their scaffolding function, our findings with SARM1 inspired us to ask whether this enzymatic activity is the primordial function of the TIR domain. Here we show that ancestral prokaryotic TIR domains constitute a new family of NADase enzymes. Using purified proteins from a cell-free translation system, we find that TIR domain proteins from both bacteria and archaea cleave NAD + into nicotinamide and ADP-ribose (ADPR), with catalytic cleavage executed by a conserved glutamic acid. A subset of bacterial and archaeal TIR domains generates a noncanonical variant cyclic ADPR (cADPR) molecule, and the full-length TIR domain protein from pathogenic Staphylococcus aureus induces NAD + loss in mammalian cells. These findings suggest that the primordial function of the TIR domain is the enzymatic cleavage of NAD + and establish TIR domain proteins as a new class of metabolic regulatory enzymes.
RESULTS
Identification of Prokaryotic TIR Domains that Induce NAD + Loss in Host E. coli
Nicotinamide adenine dinucleotide (NAD + ) biology, including the function of NAD + -consuming enzymes such as the poly(ADPribose) polymerase (PARP) and Sirtuins, profoundly influences myriad aspects of biology, from metabolism, to aging, to cancer biology, to neurodegeneration [13] [14] [15] . Previously, it was thought that the pathways regulating NAD + biosynthesis and degradation were mostly known. However, our studies showing that the sterile alpha and TIR motif containing 1 (SARM1) Toll/ interleukin-1 receptor (TIR) domain is a potent NADase necessitates a reevaluation of the function of this well-studied canonical scaffolding domain and its impact on NAD + metabolism and disease. Phylogenetic studies suggest that the TIR domain of SARM1 is closely related to prokaryotic TIR domains [16, 17] . This raises the question of whether TIR NADase activity is an evolved function unique to SARM1, or whether such an enzymatic activity may be the primordial function of TIR domains.
To distinguish between these two possibilities, we developed an assay to screen for NADase activity in host E. coli expressing candidate TIR domains ( Figure 1A ). We tested TIR domains from pathogenic bacteria, including those noted for extreme antibiotic resistance, TIR domains from non-pathogenic bacteria, TIR domains from archaea, as well as the SARM1 TIR domain (Figures 1B and 1C; Figure S1A ). As previously observed, isopropyl b-D-1-thiogalactopyranoside (IPTG) protein induction of wildtype (enzymatically active) SARM1-TIR induces NAD + loss in host E. coli ( Figure 1D ) [11] . In contrast, NAD + was not depleted after IPTG induction in E. coli harboring either a control plasmid or a plasmid encoding enzymatically dead SARM1-TIR (SARM1-TIR E642A) ( Figure 1D ). We therefore reasoned that NAD + levels would be lower in E. coli expressing enzymatically active prokaryotic TIR domains. Consistent with this hypothesis, we found that expression of TIR domains from the pathogenic bacteria Staphylococcus aureus (methicillin sensitive and methicillin resistant), uropathogenic E. coli, and Acinetobacter baumannii induced NAD + depletion in the host E. coli ( Figure 1D ). Further, TIR domains from bacteria considered non-virulent, such as Paracoccus dentrificans and Actinoplanes species or from the archaea Theionarchaea archaeon and Methanobrevibacter olleyae, also caused loss of NAD + in the host E. coli ( Figure 1D ).
These observations indicate that, like SARM1, TIR domains from diverse prokaryotes induce loss of NAD + in the E. coli host.
Characterization of an Intrinsic NADase Activity in Prokaryotic TIR Domains
The NAD + depletion observed in E. coli expressing TIR domains from multiple prokaryotic proteins stimulated us to test whether this was due to an intrinsic NAD + cleavage activity or was a secondary effect on E. coli metabolism. To test the intrinsic TIR enzymatic activity hypothesis, we adopted a cell-free protein transcription and translation system [18] that we experimentally verified is devoid of NAD + cleavage activity [11] . We used this system to synthesize double-tagged (StrepTag and 63His) TIR domains of TirS and TcpC from the Gram-positive bacteria S. aureus and Gram-negative bacteria E. coli CFT073, respectively. We also tested a TIR domain from the archaea T. archaeon, which we name TcpA-TIR. We purified the synthesized TIR proteins by tandem affinity purification and tested their ability to cleave NAD + . Cobalt beads laden with purified TIR proteins were incubated with NAD + (5 mM), and metabolites were extracted and analyzed using high-performance liquid chromatography (HPLC). All three prokaryotic TIR domains cleave NAD + , with the TIR domain of S. aureus showing the most rapid cleavage (Figure 2A) .
Because different NAD + -consuming enzymes display characteristic reaction product profiles, we asked what products were formed by these prokaryotic TIR domains. In previous work, we showed that SARM1-TIR cleaves NAD + into nicotinamide, ADPribose (ADPR), and cyclic ADPR (cADPR) [11] . Using HPLC and liquid chromatography-mass spectrometry (LC-MS), we found that all three prokaryotic TIR domains cleave NAD + into nicotinamide (Nam) and ADPR (Figures 2B-2E ; Figure S2 ). However, unlike SARM1, the S. aureus TirS-TIR and E. coli CFT073 TcpC-TIR did not produce cADPR ( Figure S2G ). A minor trace peak corresponding to cADPR was detected in LC-MS samples of the archaeal protein TcpA-TIR but was not observed on HPLC Figure S1 . Retention times were as follows: NAD + at t $2.50 min, Nam at t $2.40 min, and ADPR at t $1.10 min.
(E) Quantification of metabolites generated by prokaryotic TIR proteins as displayed in (A)-(D) (normalized to 0 min NAD). Data were generated from at least three independent reaction experiments. Data are presented as mean ± SEM; error bars represent SEM. p < 0.001 for all individual comparisons between 0 and 5 min or between 0 and 30 min for each TIR.
(legend continued on next page) chromatograms ( Figure S2G ; Figure 2D ). Hence, we conclude that the prokaryotic TIR domains from S. aureus and E. coli CFT073 possess a pure NAD + glycohydrolase activity, which is distinct from the dual NAD + glycohydrolase and cyclase activity of SARM1-TIR.
In characterizing the activity of these prokaryotic TIR domains, we examined their Michaelis-Menten parameters using the purified TIR proteins. The E. coli TcpC-TIR exhibited an estimated K m of 196 mM and a V max of approximately 1.8 mM/min, whereas the S. aureus TirS-TIR displayed an estimated K m of 490 mM and a V max of $10 mM/min ( Figure 2F) . The E. coli TcpC-TIR K m of 196 mM is very close to the reported 188 mM K m value of the bacterial virulence effector SPN (Streptococcus pyogenes NAD + glycohydrolase) that is implicated in its virulence [19] . Further, the K m values of both TcpC-TIR and TirS-TIR fall within the range of total NAD + content in E. coli and mammalian cells ($200-640 mM) [13, 20] , suggesting that these TIRs could influence NAD + levels in both eukaryotes and prokaryotes. We next investigated structural elements within these prokaryotic TIR domains that contribute to NAD + cleavage. The SARM1 TIR domain has structural similarities to nucleotide hydrolases, which led us to the identification of a glutamate residue within the proposed active site of SARM1-TIR that is absolutely essential for its catalytic activity [11] . Structural motif homology searches revealed that these prokaryotic TIRs share structural similarity with other nucleotide enzymes, including cytidine monophosphate (CMP) hydrolase and nucleoside 2-deoxyribosyltransferase (Table S1 ). No crystal structures have been reported for SARM1-TIR or the three prokaryotic TIRs so, using SWISS modeling [21] and the known CMP hydrolase structure (PDB: 4JEM), we generated structural models of the prokaryotic TIR domains. This analysis demonstrated that the catalytic glutamate of CMP hydrolase [22] aligned with a conserved glutamate in the prokaryotic TIR domains (Figures 2G and 2H; Figures S1B-S1D and S3B). The orthologous glutamate is also essential for SARM1-TIR catalytic activity ( Figure S1 ; Figure 1D ). We mutated this glutamate to alanine in each of the prokaryotic TIRs and found, in each case, that this eliminated NADase activity ( Figure 2I ; Figures S3A-S3C ). These experiments show that these TIR domains share structural homology with a family of nucleotidases, and that a conserved catalytic glutamic acid is essential for catalytic cleavage of NAD + . In some instances, NADases are capable of cleaving related molecules, such as the NAD + precursor nicotinamide mononucleotide (NMN) in the case of CD38 [23] . Further, we wanted to determine whether prokaryotic TIRs could cleave additional substrates, providing additional paths to modifying cell metabolism. To examine the substrate specificity of the prokaryotic TIR domains, we tested their activity using a variety of metabolites and analogs. These included biologically important NAD + analogs such as nicotinamide adenine dinucleotide reduced (NADH) and nicotinamide adenine dinucleotide phosphate (NADP + ) that help maintain cellular redox state [24] , key cellular energetic nucleotides such as ATP and guanine triphosphate (GTP), as well as the NAD + analogs 3-acetylpyridine adenine dinucleotide (3apAD), nicotinic acid adenine dinucleotide (NaAD), nicotinamide guanine dinucleotide (NGD), and nicotinamide hypoxanthine dinucleotide (NHD), which possess minor modifications compared to NAD + that could indicate functional groups important for catalysis (Figures 2J-2L; Figure S3D ). These studies demonstrated that all three prokaryotic TIR domains cleave NADP + but have little effect on NMN (Figures 2J-2L; Figure S3E ). The cleavage of NADP + suggests that these prokaryotic TIRs could modulate cellular function by altering the cellular NADP + pools necessary for maintaining levels of NADPH needed for reductive biosynthesis and protection against reactive oxygen species [24] . Interestingly, we also found that the SARM1-TIR domain cleaves NADP + , which provides an additional mechanism by which SARM1 could promote axon degeneration. Next, we found that whereas all TIRs substantially cleaved 3apAD and thionicotinamide adenine dinucleotide (sNAD), none cleaved NaAD (Figures 2J-2L; Figures S3E-S3G). These three NAD + analogs possess only a single functional group modification on the NAD + nicotinamide ring. For NaAD and 3apAD in particular, the amino (-NH 2 ) group of the nicotinamide ring is substituted for a hydroxyl (-OH) in NaAD or a methyl (-CH 3 ) group in 3apAD ( Figure S3D ). The differential cleavage pattern suggests that this position on the NAD + molecule is important for substrate recognition or catalysis by prokaryotic TIR domains. Additionally, we noted that whereas prokaryotic TIRs did not cleave NHD or NGD, SARM1-TIR cleaved both of these substrates (Figures 2J-2L ; Figure S3E ). Interestingly, both NHD and NGD are also cleaved by ADP-ribosyl cyclases such as CD38 [25, 26] . In particular, NGD has been used to probe the activity of proteins in the ADP-ribosyl cyclase family that generate cADPR [25, 26] . These results show clear differences between these prokaryotic TIR domains and their mammalian homolog SARM1, and are consistent with the lack of observed cyclase activity in the prokaryotic TirS-TIR and TcpC-TIR proteins.
Finally, we were unable to detect substantial cleavage of either ATP or GTP by any TIR domain, suggesting that the substrate specificity may be limited to nucleotide analogs that more closely resemble the NAD + molecule. Altogether, our results indicate that the prokaryotic TIRs are positioned to influence cellular metabolism through their cleavage of NAD + or its close analogs, and that functional groups associated with the nicotinamide ring of the NAD + molecule dictate specificity for this class of enzymes.
Identification of a Variant cADPR Generated by a Subset of TIR Domains
Our findings demonstrate that many prokaryotic TIR domains cleave NAD + to produce nicotinamide and ADPR. However, our results with archaea TcpA-TIR suggested that, like SARM1, some prokaryotic TIR NADases may also generate cADPR (Figure S2G) . Moreover, in our initial HPLC metabolite screen using the E. coli lysate assay, we observed a distinct and prominent peak (metabolite X) produced by three different prokaryotic TIRs, including the archaea M. olleyae (TcpO-TIR) and the pathogenic bacteria A. baumannii (AbTir-TIR) and Brucella sp. (BtpA-TIR) (Figures 3A-3D ; Figure S4A ). The HPLC retention time of metabolite X did not correspond to those of any known NAD + cleavage product such as ADPR, cADPR, or nicotinamide (Figures 2B-2D ), suggesting that metabolite X could be a previously unidentified product.
To identify metabolite X, we asked whether it was a direct cleavage product of NAD + or whether it was an E. coli response secondary to TIR signaling. Using our cell-free protein translation NADase assay, we tested the TIR domain from the archaea M. olleyae (TcpO-TIR). This TIR domain cleaved NAD + into nicotinamide, ADPR, and a metabolite that had a retention time very close to that of metabolite X ( Figure 3E ). These data indicate that metabolite X is a product of NAD + cleavage and raise the intriguing possibility that these TIR domains metabolize NAD + to a novel product.
To further characterize metabolite X, we performed LC-MS analysis on the extracted metabolites from the TcpO-TIR reaction. Examination of the MS spectra (m/z 70-1,200) revealed metabolites produced by the reaction (compare 0 versus 60 min) with m/z of 664, 123, 560, and 542, which correspond to NAD + , nicotinamide, ADPR, and cADPR, respectively (Figure S4B and data not shown) . Metabolite X is a molecule with an m/z of 542, which corresponds to cADPR; however, the LC retention time of m/z 542 was dramatically different from that of the cADPR standard ( Figure S4B) . Further, on a separate LC instrument, both commercially available cADPR preparations ( Figures 3F and 3G ) and cADPR generated from a SARM1-TIR programmed reaction [11] had retention times distinct from metabolite X, indicating that it is not canonical cADPR. MS/MS analysis was then used to further analyze the ion with m/z 542. We found that the major product ion had an m/z of 136, which most likely corresponds to the adenine moiety of NAD + ( Figure 3H ). MS/MS spectra of canonical cADPR showed a very similar fragmentation pattern to that of metabolite X ( Figure 3H) . Moreover, analysis from high-resolution mass spectrometry (LC/Q-TOF [quadrupole time of flight]) revealed an m/z of 542.0694 for metabolite X versus 542.0681 for canonical cADPR. To extend this analysis, we collected HPLC fractions corresponding to the metabolite X peak in lysates prepared from E. coli expressing TcpO-TIR, AbTir-TIR, and BtpA-TIR. MS/MS analysis of these fractions showed the signature m/z 542/136 ion pair was produced by each of these TIR domains ( Figures  S4C-S4E ).
These analyses indicate that a subset of prokaryotic TIR domains produces a variant of cADPR (metabolite X) from NAD + cleavage. The generation of cADPR by ADP-ribosyl cyclases, including the cyclase from Aplysia californica and mammalian CD38, occurs via cyclization at the N1 position of the adenine ring [27, 28] . In addition to this well-known N1 cyclization product, cyclization of ADPR could occur on other nitrogens of the adenine ring, including N6 and N7. Indeed, CD38 most likely cyclizes NGD, an NAD + analog, at the N7 position of the guanine ring to produce N7-cGDPR [25, 26] . By analogy, we suggest that TIR domains may produce alternative ADPR cyclization products at either N6 or N7. Hence, our results show that prokaryotic TIR domains are NAD + -consuming enzymes, and that remarkable diversity in the reaction products exists even within TIRs from the same domain of life.
Full-Length TirS from S. aureus Induces NAD + Loss in
Mammalian Cells
A number of bacterial TIR domain proteins have been identified as secreted virulence factors [6, 7] . With the discovery that prokaryotic TIR domains function enzymatically to cleave NAD + , we tested TIR domain proteins associated with microbial virulence for their ability to degrade NAD + in mammalian cells. First, we transiently expressed the TIR domains from S. aureus TirS and E. coli TcpC in HEK293T cells, extracted metabolites, and measured NAD + levels by HPLC. Consistent with results using in vitro assays, both wild-type TIR domains induced NAD + loss in these cells ( Figure 4A ). Moreover, this decline in NAD + was not observed when catalytically dead (Glu-to-Ala) mutants of these two TIR domains were tested, indicating that the intrinsic TIR enzymatic activity was responsible. We confirmed that all of these TIR domains were expressed in HEK293 cells: indeed, the mutant TIR domains were expressed at remarkably higher levels ( Figure 4B ). With confirmation that these prokaryotic TIR domains are active in mammalian cells, we set out to examine the effects of expressing the full-length S. aureus TirS virulence factor (TirS-FL) in HEK293T cells. First, we asked whether TirS-FL purified from our cell-free protein translation system was able to cleave NAD + in vitro. We found that wild-type TirS-FL cleaves NAD + , whereas the mutant TirS-FL E216A was enzymatically inactive (Figures 4C-4E ). Similar to the purified TIR-only protein, HPLC analysis showed that TirS-FL cleaves NAD + into nicotinamide and ADPR ( Figures 4C and 4D ).
To test whether TirS-FL could induce NAD + loss in mammalian cells, we transiently expressed this protein in HEK293T cells, extracted metabolites, and measured NAD + levels. Consistent with data generated in vitro and in bacteria, we found that wild-type TirS-FL induced NAD + loss in mammalian cells within 24 hr of transfection, whereas enzymatically dead TirS-FL E216A did not ( Figure 4F) . At later times, we noticed that some cells expressing wild-type TirS-FL appeared to be dying. We therefore assessed the viability of cells expressing TirS proteins via a resazurin fluorescence assay. We found that HEK293T cells expressing wild-type TirS exhibited decreased cell viability, whereas those expressing mutant TirS-FL E216A had viability similar to control ( Figure 4G ). Again, we observed that the wild-type protein was expressed at much lower levels in HEK293T cells than its catalytically inactive mutant ( Figure 4H ), suggesting that TirS may be toxic to its mammalian host. These findings suggest The scaffolding function, which is best characterized in mammalian TIR domains involved in innate immunity, may be a more recent evolutionary adaptation. Moreover, the realization that prokaryotic TIR domains are NADases enables a reevaluation of prior functional studies of these proteins. For example, our finding that the TIR domain protein from S. aureus (TirS) reduces NAD + levels in mammalian cells suggests that its role as a virulence factor could stem from its NADase activity. Additionally, many of these TIR domains cleave NADP + as well, so perturbations in redox environment could also be influenced by these virulence proteins.
The mechanism by which these proteins enter mammalian cells remains unresolved, although cytolysin-mediated translocation (CMT), a functional equivalent of the type III secretion system in Gram-positive bacteria, is thought to deliver the bacterial effector S. pyogenes NAD + glycohydrolase (SPN) [29] . Identifying how these TIRs are delivered into host cells and how the NAD + cleavage activity facilitates virulence may provide additional targets to inhibit disease pathogenesis. Finally, secreted TIR NADases may not only target eukaryotic hosts, but may also participate in bacterial competition to sculpt diverse microbial communities. The data demonstrating that purified full-length TirS is enzymatically active suggests that the enzymatic activity of TirS in S. aureus must be turned off, attenuated, or regulated in some fashion to prevent the host bacterial cell from consuming its own NAD + . In the case of SARM1, its activity is regulated by unknown mechanisms involving the auto-inhibitory N-terminal domain and by the actions of the NAD + synthesis enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) [30] [31] [32] . It is likely that similar auto-inhibition or a toxin-antitoxin system [33] is present to regulate TIR domain activity in the host bacterial cell.
The presence of TIR domain proteins that cleave NAD + in non-pathogenic bacteria and archaea suggests that these proteins also play non-virulence-related roles, most likely in regulating metabolic pathways. For example, the generation of adenine-derived second messengers such as ADPR and cADPR by this TIR family could control calcium homeostasis, which helps regulate chemotaxis [34] . It remains to be determined whether the variant cADPR molecule (metabolite X) can substitute for cADPR in inducing calcium release or whether it has completely novel functions. Additionally, these initial studies of TIR domains focused on NAD + metabolism; however, their structural homology to nucleotide hydrolases [11, 35] opens the possibility that subsets of TIR domains could have even more diverse roles and modulate other aspects of nucleotide metabolism.
In summary, we have discovered that a diverse set of prokaryotic TIR domains regulates levels of the central metabolic regulator NAD
+ . These results demonstrate that TIR domain proteins constitute a new family of NADases, and suggest that the TIR domain scaffolding functions in Toll-like receptor (TLR) signaling most likely represent a ''repurposing'' of this evolutionary ancient enzymatic domain.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: (F) , and (G) were generated from at least three independent experiments. Data are presented as mean ± SEM; error bars represent SEM. ***p < 0.001, unpaired two-tailed Student's t test.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Recombinant DNA and Endogenous NAD + measurements in host E. coli Double tagged (N-terminal tandem StrepTag and C-terminal 6xHisTag) bacterial, archaea, and SARM1 TIRs (see sequence in Figure S1 ) were cloned into a pET30a+ plasmid. These constructs as well as non-recombinant pET30a+ were transformed into Shuffle T7 Express Competent E-coli (New England BioLabs). Single colonies were then grown overnight and the next day, cultures were diluted in LB media, grown at 30 C until they reached A 600 of approximately 0.4-0.8, when IPTG (0.1 mM final concentration) was added to induce protein expression. The cultures were then harvested at approximately 30 min ( Figure S3 ) or 2 hr later (Figure 1D) . The cultures were normalized to A 600 of approximately 0.5 ± 0.05 and the pellet from 500 mL of culture suspension was lysed by adding 200 mL 0.5M perchloric acid (HClO 4 ). Samples were then placed on ice for at least 10 min, centrifuged, and supernatant collected. 180 mL of supernatant was then added to approximately 67 mL of 3M K 2 CO 3 . Samples were placed on ice for at least 10 min, and centrifuged. NAD + metabolites were then measured by HPLC as described in Method Details section. Extracted metabolites after perchloric acid or K 2 CO 3 addition can also be stored at À20 C for later processing.
Cell-free protein transcription and translation
In vitro cell-free protein transcription and translation was performed using the PURExpress In Vitro Protein Synthesis Kit (New England BioLabs Catalog # E6800S). For a total reaction volume of about 25 mL, the reaction was assembled in the following order: 10mL of Solution A, 7.5mL of Solution B, 3mL of RNase inhibitior (40U/uL), water, and 0.5-1.0 mg of pET30a+ non-recombinant/recombinant DNA. The reaction was incubated at 37 C for 2.5 hr and stopped by placing on ice. Multiple 25 mL reactions can be pooled together to increase protein yield prior to Tandem Affinity purification of proteins, which is described in the Method Details section.
Mammalian Cell Culture and NAD + quantification
HEK293T cells were maintained in 10% FBS in DMEM, supplemented with penicillin/streptomycin and glutamine, and passaged by suspending in 0.05% trypsin. For NAD + measurements in mammalian cells, HEK293T cells were seeded in 12-well dishes (approximately 2.5 3 10 5 cells per well) and transiently transfected the following day with 500 ng of the indicated plasmid using polyethylenimine (1mg/mL) in a 3:1 ratio to plasmid DNA. Twenty-four hours later, cells were washed in cold phosphate buffered saline and NAD + extracted using perchloric acid method. NAD + was measured after separation by HPLC.
METHOD DETAILS
Identification of prokaryotic TIR domains and database search Candidate pathogenic bacterial TIRs were selected from the published literature where at least seven bacterial TIR domain proteins have been reported to promote virulence [9] . A. baumannii was included since carbapenem-resistant A. baumannii is classified under 'Priority 1' of the 2017 WHO Priority Pathogens List for R&D of New Antibiotics. P. dentrificans TIR domain is not known to promote virulence but was one of the first bacterial TIR domains where the crystal structure was available [9] . The archaeal TIR domains were identified by searching the non-redundant protein database in protein-BLAST, and selecting Archaea (taxaid:2157) under Organism. The blastp (protein-protein blast) algorithm was utilized and the search was performed using the sequence of the bacterial TIR domains TirS-TIR and TcpC-TIR (see sequence in Figure S1 ). Both M. olleyae and T. archaeon ranked as the top 2 hits with highest max score, and lowest e-value in the search using TirS-TIR, and T. archaeon ranked the highest in the max score and identity, and lowest e-value in the search using TcpC-TIR. The TIR domain from Actinoplanes was identified from bioinformatics analyses establishing a phylogenetic relationship between SARM1-TIR and other TIR domains. NADase assay and metabolite extraction For purified TIR domains, typically, 10-20 mL of cobalt beads laden with purified protein were incubated with 5 mM NAD + and reaction buffer (92.4 mM NaCl and 0.64X PBS), for a total reaction volume of 50 mL. Reactions were carried out at room temperature (25 C) for the indicated amount of time. For biotin eluted TirS-FL, 20 mL (wild-type) or 30 mL (mutant) protein was incubated with 5 mM NAD + , under the same buffer and temperature conditions. Reaction was stopped by addition of 50 mL 1M of perchloric acid (HClO 4 ) and placing the tube on ice for at least 10 min. Neutralization was performed with 16.7 mL 3M K 2 CO 3 . Samples were placed on ice for 10 min, and then separated by centrifugation. NAD + metabolites were quantified by HPLC (see HPLC metabolite measurement).
For LC-MS analysis, the extraction was performed using 50% Methanol in water, and chloroform extraction (see LC-MS metabolite measurement for further details). Extracted metabolites after perchloric acid or K 2 CO 3 addition can also be stored at À20 C for later processing.
Purification of Metabolite X from bacterial lysates Purification and separation was performed using HPLC (Prominence; Shimadzu) equipped with C-18 column (150 3 4.6mm, 3 mm; Supelco) at flow rate of 1mL/min with 5mM ammonium formate for mobile phase A and 100% methanol for mobile phase B. Metabolites were eluted with gradients of 0-5 min, 100% A; 5-6 min, 0%-5% B; 6-13 min, 5% B; 13-15 min, 5%-15% B; 15-23 min, 15% B; 23-24 min, 15%-0% B; 24-30 min, 100% A and eluents between 3-4 min containing metabolite-X were collected, lyophilized, and stored at À80 C until analysis.
LC-MS metabolite measurement
Samples were prepared by mixing the reactions with 50% methanol in water. The samples were placed on ice (or stored at À20 C for later processing), centrifuged, soluble metabolites in the supernatant were purified with chloroform extraction, and the aqueous phase was lyophilized and stored at À20 C until LC-MS analysis. For LC-MS, the metabolite samples were reconstituted with 5 mM ammonium formate, centrifuged 12,000 x g for 10 min, and the cleared supernatant was applied to the LC-MS for metabolite identification and quantification. Liquid chromatography was performed by HPLC system (1290; Agilent) with Atlantis T3 C18 (2.1 3 150 mm, 3 mm; Waters) column. Samples (10 mL) were injected at a flow rate of 0.15 mL/min with 5 mM ammonium formate for mobile phase A and 100% methanol for mobile phase B and metabolites were eluted with gradients of 2-6 min, 0%-20% B; 6-8 min, 20%-50% B; 8 -10 min 50% B; 10 -15 min, 50 -0% B. The metabolites were detected with Triple Quad mass spectrometer (6470; Agilent) under positive ESI multiple reaction monitoring (MRM). Metabolites were quantified by MassHunter quantitative analysis tool (Agilent) with standard curves. Standard curves for each compound were generated by analyzing NAD+, cADPR, ADPR, and Nam reconstituted in 5 mM ammonium formate., For high resolution Q-TOF analysis of Metabolite X, extracted metabolites from TcpO-TIR reaction were detected by Q-TOF (6545; Agilent) with direct infusion at flow rate of 0.5 mL/min of mobile phase (50% acetonitrile and 50% water) and m/z for metabolite-X was determined by comparing m/z profiles with that of control.
Cell Viability Studies HEK293T cells were seeded in 96-well plates and transfected with 10ng of the indicated plasmid with polyethylenimine (1mg/mL) (3:1 ratio to plasmid DNA). At 48 hr post-transfection, cells were washed in phosphate buffered saline (PBS) then incubated with 0.01mg/mL resazurin (Sigma-Aldrich Cat# R7017) diluted in PBS for 1 hr at 37 C. Fluorescence intensity was measured with a POLARstar Optima plate reader (BMG Labtech) with 544 excitation and 590 emission filters. At least three wells were assessed per replicate for each condition.
SYPRO Ruby Gel Staining
Purified proteins were boiled in Laemmli buffer for 5-10 min and separated on a 4%-12% Bis-Tris Plus gel. After electrophoresis, the gel was fixed in 50% Methanol/7% acetic acid for 30 min x 2, then incubated overnight in SYPRO Ruby Protein Gel stain (Thermo Fisher). The next day, the gel was washed with 10% methanol/7% acetic acid solution for 30 min, rinsed in distilled water for 5 min x 2, and stained proteins were visualized with a UV transilluminator.
Western Blot
For expression studies in HEK293t cells, the cells were seeded and transfected as described for NAD analysis. One day post transfection, cells were washed with PBS and lysed in Laemmli buffer. Cell extracts were briefly sonicated, centrifuged at 5,000xg for 5min to remove cell debris. The supernatants were then boiled, resolved by SDS-PAGE followed by immunoblotting for Flag (1:1000 Mouse Anti-Flag M2 monoclonal, Sigma F3165) and beta-tubulin (1:1000 Anti-beta-tubulin DSHB Clone E7) and visualization by standard chemiluminescence.
Enzyme kinetics studies V max , and K m were determined from the initial reaction velocity or reaction velocity in the first 60 s of product (ADPR) formation, and fitting the data to the Michaelis-Menten equation using nonlinear curve fit in GraphPad Prism 7. Data are presented as Mean ± SEM from two independents biological samples and a total of four independent reaction measurements.
Structural Modeling of bacterial TIR domains SWISS-Model [21] was used to generate structural models of bacterial TIR domains. The crystal structure of MilB CMP hydrolase (PDB 4JEM) was used as the template. The modeled bacterial TIR domain and MilB crystal structures were visualized and superimposed with Chimera (https://www.rbvi.ucsf.edu/chimera). tan -modeled bacterial TIR; cyan -MilB CMP hydrolase; yellow -CMP (ligand for MilB).
HH Pred Protein Identification
TirS-TIR, TcpC-TIR, and TcpA-TIR were analyzed for structural homologs using HH Pred [36] . Only known nucleotide enzymes with an E-value lower than 0.1 and a probability above 95% are shown in Table S1 .
QUANTIFICATION AND STATISTICAL ANALYSIS
Unpaired two-tailed t tests were used for individual comparisons with an assumption of equal variance between groups. All error bars represent SEM. Other data analyses were done with Graph Pad Prism 7, Microsoft Excel, Adobe Illustrator and Photoshop.
